New preprint out today! Another study from our great collaboration with @DrFredLocke @DrJonSchatzMD @BachisioZic @MSKCancerCenter @MSK_DeptOfMed @MoffittNews @univmiami. We show that CAR T efficacy depends on host T cells and HLA recognition. #lymsm #CART biorxiv.org/content/10.648…
Francesco Maura
@FrancescoMaura4
Assistant Member, @MSKCancerCenter , @MSK_DeptOfMed, #NYC, myeloma, #mmsm, genomics, #WGS, #haematology
1K Following 1.7K Followers 2.3K Posts
Latest posts 5
This is a clinical practice-changing study showing how to identify patients without GPRC5D who are therefore refractory to anti-GPRC5D therapies. The great news is that this is based on IHC ➡️easy to use in clinic. #IMS26 @MSKCancerCenter @szusmani
(TODAY) Stop by our poster to learn how to better treat patients with #GPRC5D-related therapies!View quoted post on X
#mmsm #IMS2026
nature.com/articles/s4146…View quoted post on X
There are two key takeaways:
1) A EOMES+GZMK+ transcriptional state defines myeloma CAR T cell efficacy.
2) Viral promoter choice, rather than unique binder design, explains how CAR T cells achieve this state and cilta-cel's superior efficacy.
New paper out today in @BCD_AACR, focused on how RHOA contributes to CAR-T resistance in large B-cell lymphomas! Another paper from our great ongoing collaboration with @DrJonSchatzMD @DrFredLocke #wgs #lysm @MSKCancerCenter @MSK_DeptOfMed @MoffittNews @SylvesterCancer. Link 👇
Happy to be in Houston and attend for the first time #SOHO2026! Looking forward to connect with friends and colleagues and present tomorrow our data on myeloma precursor conditions MGUS and SMM. @MSKCancerCenter #mmsm